Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Massage × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Wounds and Injuries 1 Stroke 1 Sepsis 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Neoplasms 1 Kidney Failure, Chronic 1 Heart Failure 1 HIV Infections 1

Interventions

Docetaxel 264 Prednisone 209 enzalutamide 169 Leuprolide 162 Radiotherapy 153 Abiraterone Acetate 148 Magnetic Resonance Spectroscopy 140 bicalutamide 115 Goserelin 115 Androgen Antagonists 103 Radiosurgery 99 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 97 apalutamide 82 gallium 68 PSMA-11 68 Specimen Handling 68 abiraterone 67 darolutamide 57 Gonadotropin-Releasing Hormone 54 Surveys and Questionnaires 53 Biopsy 53 Radiation 51 Brachytherapy 50 cabazitaxel 49 Triptorelin Pamoate 47 Standard of Care 44 pembrolizumab 43 Zoledronic Acid 43 luprolide acetate gel depot 42 Radiotherapy, Intensity-Modulated 41 Estramustine 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05067777 2025-12-15

mPROSTATE

University of Utah

Phase 2 Terminated

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡